Khavinson Peptides is a recurring topic in our peptide coverage. This hub collects every article tagged Khavinson Peptides, newest first, each evidence-graded and tied to real, verifiable sources.
A clinical monograph on Vilon — the synthetic Lys-Glu dipeptide bioregulator marketed for immune and longevity support. Rodent and in-vitro signals only, no human RCT, and no legal compounding pathway in 2026.
A clinical monograph on Thymalin — the calf-thymus immune bioregulator from Khavinson's lab. Real human trial data graded B, a single-lineage evidence base, and a non-FDA-approved 2026 status.
A clinical monograph on Prostamax — the synthetic prostate-tropic tetrapeptide Lys-Glu-Asp-Pro (KEDP) from the Khavinson school. The human prostate evidence belongs to the parent bovine-prostate extract, not the synthetic peptide.
A clinical monograph on Pinealon (Glu-Asp-Arg / EDR), the Khavinson ultrashort neuroprotective tripeptide. Reproducible preclinical antioxidant data, no human RCT, and an unapproved 2026 legal status.
A clinical monograph on Cortagen (Ala-Glu-Asp-Pro) — the Khavinson-program 'cytogen' tetrapeptide marketed for nerve repair and neuroprotection. One intriguing rat nerve-regeneration signal, no human RCTs, and an unapproved-research-chemical legal status.
A clinical monograph on Bronchogen — the lung/bronchial 'bioregulator' tetrapeptide (ADEL/AEDL) from the Khavinson short-peptide program. Promising preclinical biology, zero human efficacy or safety trials, and an unapproved 2026 legal status.
Khavinson Peptides is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
This hub updates automatically whenever a new article is tagged Khavinson Peptides, so the latest coverage appears first.
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.